BLOOD PRESSURE AND PLASMA FGF-23 CONCENTRATION CHANGES AFTER CINACALCET TREATMENT IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Adamczak, M. [1 ]
Kuczera, P. [1 ]
Wiecek, A. [1 ]
机构：
[1] Dept Nephrol Transplantol & Internal Med, Katowice, Poland
来源：
JOURNAL OF HYPERTENSION | 2015年 / 33卷
关键词：
D O I：
10.1097/01.hjh.0000468926.58110.3f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.39.14
引用
收藏
页码：E488 / E489
页数：2
相关论文
共 50 条
  • [31] Impact of serum FGF23 levels on blood pressure of patients with chronic kidney disease
    Li, J. -X.
    Yu, G. -Q.
    Zhuang, Y. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (03) : 721 - 725
  • [32] Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients
    Fragoso, Andre
    Silva, Ana Paula
    Gundlach, Kristina
    Buechel, Janine
    Neves, Pedro Leao
    CLINICAL KIDNEY JOURNAL, 2014, 7 (02) : 161 - 166
  • [33] Estimation of FGF-23 level in patients with chronic kidney disease with or without vitamin D supplementation
    Sheikh, S.
    CLINICA CHIMICA ACTA, 2024, 558
  • [34] Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis
    Mei, Changlin
    Chen, Nan
    Ding, Xiaoqiang
    Yu, Xueqing
    Wang, Li
    Qian, Jiaqi
    Wang, Mei
    Jiang, Gengru
    Li, Xuemei
    Hou, Fanfan
    Zuo, Li
    Wang, Niansong
    Liu, Hong
    HEMODIALYSIS INTERNATIONAL, 2016, 20 (04) : 589 - 600
  • [35] Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
    Pereira, Renata C.
    Juppner, Harald
    Azucena-Serrano, Carlos E.
    Yadin, Ora
    Salusky, Isidro B.
    Wesseling-Perry, Katherine
    BONE, 2009, 45 (06) : 1161 - 1168
  • [36] Role of Morphogenetic Proteins - FGF-23 and Klotho in the Vascular Calcification in Patients with Chronic Kidney Disease
    Plotnikova, Alexandra
    Milovanova, Ludmila
    Milovanov, Yurii
    Moiseyev, Sergey
    Kozlovskaya, Lydia
    Mukhin, Nikolay
    Kryukova, Daria
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [37] Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
    Muras-Szwedziak, Katarzyna
    Pawlowicz-Szlarska, Ewa
    Nowicki, Michal
    RENAL FAILURE, 2023, 45 (01)
  • [38] FGF-23, SKLOTHO AND SCLEROSTIN IN ASPECT OF VASCULAR CALCIFICATION IN RUSSIAN CHRONIC KIDNEY DISEASE PATIENTS
    Milovanova, Ludmila
    Lysenko , Lidia
    Vervloet, Marc
    Fomin, Victor
    Milovanov, Yuriy
    Kozlov, Vasiliy
    Taranova, Marina
    Milovanova, Svetlana
    Reshetnikov, Vladimir
    Kozevnikova, Elena
    Brovko, Mihail
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [39] Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis
    Montenegro, Jesus
    Isabel Gallardo, Inaki Cornago
    Garcia-Ledesma, Paula
    Hernando, Ainhoa
    Martinez, Isabel
    Munoz, Rosa I.
    Romero, Marco A.
    NEPHROLOGY, 2012, 17 (01) : 26 - 31
  • [40] IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS
    Milovanov, Yuriy
    Dudareva, Anna
    Milovanova, Ludmila
    Kozlovskaya, Lidia
    Mukhin, Nikolay
    Lebedeva, Marina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1469 - 1470
12345